gip/glp-1 agonists GLP-1/GIP Receptor and Diabetic Retinopathy: What ODs Should Know Effects, working principles and target
Description
However, there may be unappreciated benefits of this combination of therapies
Mercedez Hernandez walks through what patients should consider when weighing their options.
New research is taking a closer look at what can happen when people stop taking GLP-1 medications for a long period of time.
Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain
Grocery list included.
